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Ionizing radiation has been associated with various cardiovascular 
complications; however, the associated molecular changes from radiation 
exposure still remain largely uncharacterized. Alterations to the cardiovascular 
tissue microenvironment, i.e. the extracellular matrix (ECM), directly affect the 
function of integrated vascular cells, including cell adhesion, potential to form 
vessels, and endothelial permeability, which can promote cardiovascular 
pathologies. The ECM is constantly remodeled in response to stimuli, such as 
TGF-β1, which leads to excessive ECM accumulation. We hypothesize that 
radiation exposure will alter the cardiovascular ECM.  Human Cardiac Fibroblasts 
(HCFs) were utilized to produce ECM as an in vitro model to study changes in 
cardiovascular ECM from exposure to 0 and 1 Gy of γ-radiation.  We verified that 
the ECM produced by these cells over 7 days of culture contained collagen and 
fibronectin.  HCFs were radiosensitive to 1 Gy of radiation, as the irradiated cells 
exhibited γ-H2AX foci.  Intracellular reactive oxygen species (ROS), a known 
activator of latent TGF-β1, was increased in HCF immediately after radiation.  In 
addition, irradiated HCF contained SMAD 2/3 in their nuclei and expressed α-
smooth muscle actin, which are indicative of TGF-β1 activation.  Measurement of 
total ECM protein and morphology demonstrated an increase in ECM protein 
production and an altered ECM structure from HCF exposed to 1 Gy radiation 
compared to sham control.  In conclusion, we demonstrate that ionizing radiation 
induces structural and molecular changes in cardiovascular ECM.  Our data 
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further indicates that γ-irradiation activates TGF-β1 downstream signaling 
cascades, which may be a primary contributor of ECM remodeling in vascular 
tissue.  Future studies relating ECM remodeling and cardiovascular cell function 
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Exposure to ionizing radiation is an important concern in medical 
radiotherapy [1], occupational exposure [2-4], and manned space flight [5].  
Different types of ionizing radiation can include Beta radiation (β-radiation), 
gamma radiation (γ-radiation), and high energy cosmic (HEC) radiation.            
γ-radiation can penetrate several centimeters into the skin, whereas gamma 
radiation (γ-radiation) can penetrate through the skin and into the human body.  
Exposure to γ-radiation injury can induce morphological and functional changes 
in noncancerous or normal tissue.  Associated hazards of ionizing radiation 
exposure can include the development of cardiovascular diseases, carcinogenic 
events [6], and congenital abnormalities [7].  Many studies have indicated a strong 
connection between ionizing radiation exposure and diseases; however, little is 
known about the pathophysiology of these phenomena.  Although, it is a widely 
accepted fact that ionizing radiation induces an excess in exogenous reactive 
oxygen species (ROS). [8] These ROS species may prove to shed insight into the 
mechanism(s) linking ionizing radiation to a variety of diseases.     
ROS refers to chemically reactive molecules (free radicals) with oxygen, 
such as peroxides, hydroxyl radicals, and singlet oxygens.  ROS are important 
homeostatic molecules in non-diseased states.  However, shifts in the equilibrium 
of ROS and ROS scavengers, known as antioxidants (AOXs), can induce oxidative 
stresses in cells and tissues.  This oxidative stress contributes to non-
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homeostatic conditions in the cell’s microenvironment as well as induces DNA 
damage [9].  One possible way to cause this shift in equilibrium is via ionizing 
radiation exposure.  In order to combat this equilibrium shift, cells utilize intrinsic 
(superoxide dismutase, catalase, glutathione, proteins, etc) and extrinsic (vitamin 
C and E, polyphenols, carotenoids, etc.)  AOX that scavenge excessively 
produced ROS. [10, 11] The basic mechanism behind AOX requires that they 
donate electrons to ROS molecules in order to “deactivate” the free radical from 
causing oxidative stress.  The balance of ROS and AOX activity is an ongoing 
process throughout the cell’s entire life.     
The continually changing proportions of ROS and AOXs, both 
intracellularly and extracellularly, create a diverse environment that makes 
modeling in-vivo conditions challenging for the accurate predictions of the risks 
of radiation.  Previous methods of modeling human radio-sensitivities include 
coupling empirical evidence with radiative transfer models [12], biophysical 
models [13] or normal tissue complication probabilities. [14] However, these models 
only utilize uniform irradiation of populations at high doses whereas Ward et. al 
[15] has proven even significant effects can occur at low doses.  Moreover, 
these models do not propose any new advances in understanding the 
mechanisms underlying irradiation exposure and its effects on cells 
and tissues.  Advances in cell culture methods, multidisciplinary 
research, and an increased clinical need for treatment of radiation 
induced injuries has led to a paradigm shift utilizing in-vitro models to 
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elucidate the biological mechanisms involved in pathophysiological 
conditions resulting from radiation exposure. 
 
Radiation Effects on the Cardiovascular Environment 
It is now recognized that the heart is susceptible to radiation exposure. [16] 
Many negative effects have been associated with mediastinal irradiation.  Effects 
can include coronary artery disease, pericarditis, cardiomyopathy, valvular 
disease, and conduction abnormalities.  Some of these effects have been 
observed in populations of cancer patients receiving radiation treatment [5, 17], 
nuclear industry workers, [2, 4], and atomic bomb survivors [5, 17, 19].  These 
observations have also suggested radiation-associated cardiovascular toxicity 
may be progressive. [18] Atomic-bomb survivors presented premature aortic arch 
calcification, isolated systolic hypertension, and myocardial infarction [16, 19]. 
Moreover, patients receiving radiation therapy for Hodgkin’s disease or left-sided 
breast cancer demonstrate an elevated risk of coronary heart disease, 
arteriosclerosis, atherosclerosis, and late-pulmonary fibrosis [20,22-26,34,35].   
Many of the aforementioned cardiovascular diseases are linked in that 
their pathologies show an increase in vascular stiffness.[27-29]  Arterial stiffness 
develops from complex interactions between stable and dynamic changes 
involving structural and cellular components. [30-32] The main structural 
components of the arterial wall are two extracellular matrix (ECM) proteins: 
collagen and elastin.  Collectively these proteins determine resilience, 
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compliance, and stability of the vessel wall.  In diseased states, there is a 
dysregulation in the balance of these proteins as well as chondroitin sulfate, 
heparin sulfate, proteoglycans, and fibronectin (FN) [31].  Some ECM matrix 
proteins contain cryptic sites which are active fragments that are not normally 
exposed in the protein.  These sites are exposed by structural or conformational 
changes in the ECM protein and lead to altering the structural (matrix assembly, 
fiber alignment, composition) & mechanical (elastic moduli, stiffness, and 
porosity) [33] properties of the ECM directly. These local changes can in turn 
cause global affects through signal transduction cascades in the function of 
integrated vascular cells such as endothelial cells, fibroblasts, and vascular 
smooth muscle cells.   
 
ECM and Cell Signaling  
The ECM has long considered to be an inert, purely supportive, 3D network 
of proteins (collagenous and non-collagenous) and glycosaminoglycans (GAGs) 
for the cellular microenvironment.  Additionally, the matrix provides a medium 
for cellular migration and interaction during their development, homeostasis, & 
regeneration. Moreover, it can provide an adhesive substrate for cells, transduce 
mechanical signals, regulate cell morphology and functions, such as 
differentiation, proliferation, and migration, and sequester and store cytokines, 
such as growth factors [8,10,36]. Cellular responses are tissue dependent in terms 
of both biochemical and biomechanical cues.  Hence, understanding the 
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complexities surrounding ECM production, modification and remodeling, and 
relating these processes to physiological changes in the biochemical and 
biomechanical properties of the ECM, are key to determining how 
microenvironmental changes influence cellular responses.[37] Thus, the cell’s fate, 
life and death, is ultimately related to and dependent on the interaction, 
composition, and organization of the matrix.   
Each component of the ECM is unique and together the ECM components 
dictate the mechanical, structural, and biochemical microenvironment. For 
example, collagen I (Col I) fibrils provide tensile strength, collagen III (Col III) 
fibrils colocalize with collagen I fibrils and modulate its production, and 
proteoglycans, such as FN, act as adhesive substrates for cells and other matrix 
proteins [8,38-39].  Due to the negative charge of GAGs, they’re able to alter 
activities of other molecules such as fibroblast growth factor, chemokines, 
cytokines, and those of the transforming growth factor family. [38,40].  In most 
connective tissue, ECM is primarily produced and organized by fibroblasts, which 
are constantly remodeling the ECM through the peptide growth factor regulated 
matrix metalloproteinases and their inhibitors.   
Peptide growth factors are small proteins that regulate cell differentiation, 
proliferation, and apoptosis.  Those of the transforming growth factor family 
(TGF-β) are molecules that are also highly involved in regulating the ECM and 
have been noted to play a significant role in the regulation and growth of 
normal, hyperplastic, and malignant prostatic epithelium.  TGF-β is a broad term 
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encompassing five different conformations of the protein (TGF-β1-5) with only 
TGF-β1-3 expressed in mammals.  Specifically, TGF-β1 upregulates several 
fibrotic genes encoding fibronectin, collagens, and can activate other proteins 
through its type I receptor. [41] Fibroblasts secrete TGF-β1 as an inactive 
precursor as part of a protein complex where the ECM acts as a reservoir of this 
quiescent TGF-β1 [42-44].  For TGF-β1 to bind to its cell receptor, it must be 
activated by low pH, proteases, deglycosylation, plasmin, thrombospondin, 
integrins, radiation exposure, and ROS as well as other mechanisms [45-47]. In 
cancer models, ROS are extremely efficient activators of TGF-β1 [42,46]. This 
activated TGF-β1 is then free to interact with its associated receptor kinase on a 
cell membrane.  Upon binding to the receptor it induces fibroblast differentiation 
into myofibroblasts which express α-smooth muscle actin (α-SMA).  
Myofibroblasts are associated with diseased states characterized by excessive 
ECM secretion.  Abnormal radiation induced production of TGF-β1 has already 
been linked to cancer progression [48,49] and development of fibrosis in skin, lung, 
gut and liver [50]. Limited studies have explored the effects of TGF-β1 on 
cardiovascular ECM and its role in cardiovascular disease progression. 
 
Fibroblast-derived ECM 
Cell derived ECM scaffolds have been more recently explored as alternatives 
to investigating cellular and protein level changes in tissues.  These ECMs are 
naturally produced by fibroblasts and have been shown to be similar in 
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composition, microstructure, biochemical properties, and bioactivity to those of 
the native tissues and organs. [51, 52] These ECMs are a multi-component 3D 
scaffold containing proteins, GAGs, and growth factors [44, 52]. The mechanical 
properties of cell derived ECM have been examined.  Decellularized ECM (dECM) 
has been additionally utilized in studies in order to show its effects on cell 
adhesion, endothelial tubulogenesis, and other cell processes as they relate to 
disease progression. [53, 54]  Moreover, TGF-β1 activation has been investigated 
using decellularized lung fibroblast-derived matrices [44] whereas few studies 
have examined non-homeostatic conditions on cell derived cardiovascular 














 We hypothesize that a human cardiac fibroblast in vitro model can be 
designed in order to investigate that γ-radiation exposure increases ROS, which 
contributes to the increased production of ECM proteins thus altering their 
structure and function.  In order to achieve this goal, the process was threefold:  
1. Develop a fibroblast cell culture model that allows for the production of a 
cardiovascular specific decellularized ECM  
2. Examine the radiosensitivity of the fibroblast model developed in aim 1  
3. Investigate radiation-induced changes to the decellularized ECM produced 














Culturing of Fibroblasts 
HCFs were obtained from Promocell and cells were cultured in Fibroblast 
Growth Medium 3 (Promocell) supplemented with 10% fetal bovine serum (FBS; 
Atlanta Biochemical) and 1% penicillin/streptomyosin (PS; HyClone).  All 
subcultures were seeded at a minimum density of 4000 cells/cm2.                   
All experiments were conducted with HCFs less than or equal to passage 6.   
 
Seeding Cell Culture Plates to Produce ECM 
ECM was produced on either 12 mm fibronectin coated glass coverslips 
(Fisherbrand) or 30 mm fibronectin coated sterile 6 well culture plates (Costar).  
Coverslips were sterilized by submerging each coverslip in 70% (v/v) ethanol 
(Decon Labs) for 30 seconds and allowed to air-dry and placed into wells of a 12 
well plate.  Plate wells were then treated with either 1 or 2 mL (6 or 12 well 
plate, respectively) of a 50 μg/μL (w/v) fibronectin (Corning) solution in 
deionized water (DI H2O).  Once the fibronectin solution was added, the plates 
were then incubated for 1 hour at 37°C to allow the fibronectin solution to coat 
the coverslips or wells.  Coating with fibronectin allowed the ECM produced by 
the HCFs to stay attached to the cell culture plates and coverslips post 
decellularization.  Cells were then added to all necessary wells at 100% 
confluence to 6 or 12 well plates (40,000 or 200,000 cells/well, respectively) post 
incubation.  Upon addition to cell culture plates, HCFs were cultured for 14 days 
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with media changes every 2 to 3 days.  For ECM requiring experiments, cells 
were radiated with 0 or 1 Gy of γ-radiation and/or treated with an AOX 
(immediately before radiation) on day 7 using a Gammacell 40 Extractor (MDS 
Nordion) irradiator.  For cell only requiring experiments, cells were cultured for 
only 3 days with radiation exposure and/or AOX treatment on day 3.  1 Gy of γ-
radiation was used due to mandates set by the funding institution.      
 
Preparation of Antioxidant Cocktail 
 An AOX cocktail was utilized in order to reduce any ROS generated from 
γ-radiation exposure.  The reduction in ROS is used to compare the effects of 
diminished ROS on the cells and their microenvironment (ECM) to that of the 
base conditions, 0 or 1 Gy of γ radiation.  The specific concentration of the AOX 
cocktail used across all experiments was a mixture of a 103 Units/mL of 
polyethylene catalase (PEG catalase; Sigma) and a 10 μM solution of Manganese 
(III) tetrakis (4-benzoic acid) porphyrin chloride (MnTBAP; Calbiochem). This 
AOX cocktail was used due to its structure and mechanisms.  Structurally, these 
AOXs are able to have successful cellular uptake upon exogenous treatment.  
Mechanistically, the treatment of these two allow for an effective two step 
procedure for reduction ROS (MnTBAP reduction of ROS to H2O2 followed by 
catalase reduction of H202 to water).
 [55] PEG catalase was initially a 1 mg 
lyophilized powder and was reconstituted based on manufacturer specifications 
in a 1:1 solution of DI H20 and Glycerol (Sigma) for a total of 2 mL.  This 
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resulting 0.5 mg/mL solution was placed into 50 μL aliquots and frozen at -20°C 
until further use.  The MnTBAP was freshly prepared before each experiment 
with 1 mg of MnTBAP reconstituted in 2 mL of a  .01 M Tris base solution 
(Sigma; pH ~ 7.0 -7.4; 36.3 mg Tris base dissolved in 3 mL of DI H2O).  This 
resulting concentration of 0.5 mg/mL MnTBAP was used in obtaining the desired 
concentrations of the AOX cocktail needed for each experiment.  To obtain the 
desired concentration, the AOX is mixed in the ratio of 51.3 μL of PEG catalyse to 
17.5 μL of MnTBAP to 931.2 μL of 1X-phosphate buffered saline (v/v) 
supplemented with 0.9 mM Ca+2 + 0.5 mM Mg+2 (1X-PBS (+Ca/Mg)) for a total 
of 1 mL AOX created.  These ratios were adjusted throughout all experiments to 
obtain the necessary volume of the AOX cocktail needed.  All solutions and 
powders were kept on ice and handled in low light due to the stability of the 
AOX.      
The AOX cocktail is utilized in creating the 4 experimental conditions in 
Table 1 for all further experiments.  In order to compare the effects of AOX 
treatment on cells and ECM production, all appropriate HCFs were introduced 
with the AOX cocktail immediately before irradiation.   
TABLE 1: Experimental Conditions 
 RADIATION (0 or 1 Gy) 
ANTIOXIDANT 
(+ or -) 
0 Gy/No Antioxidant (NR) 1 Gy/No Antioxidant (R) 
0 Gy/Antioxidant (NR-AOX) 1 Gy/Antioxidant (R-AOX) 
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Detection of ROS in HCFs 
HCFs were seeded at 10,000 cells/well in 15 wells across 2 flat black 96 
well plates (Costar) for a total of 30 wells seeded (3 conditions per plate, 5 
replicates per condition, 2 plates designated NR and R).  Based on previous work 
in the lab, cells were not seeded along the outer wells of each plate in order to 
avoid plate reader induced errors of measurements.  All further work was 
completed in low light conditions due to the photo stability of the AOX and dyes 
used in the procedure.   
Following one night of incubation, cell media was vacuumed up from each 
well and cells were washed for 5 minutes with 100 μL of a sterile 1X-PBS 
+Ca/Mg solution.  This mixture of PBS was used in order to avoid cell lysis or 
shrinkage.  After 5 minutes, the PBS solution was vacuumed off and all cells 
were treated with 100 μL of a 10 μM 2’, 7’-di-chloro-di-hydro-fluorescein 
diacetate dye (DCFH-DA; Life Technologies) in 1X-PBS +Ca/Mg and incubated at 
37°C for 30 minutes.  DCFH-DA is normally a lyophilized powder that was 
reconstituted in 8.16 μL of DMSO to create a stock 10 mM solution.   Post 
incubation, all wells were washed with 1X-PBS +Ca/Mg and then treated again 
with 100 μL of the 1X-PBS +Ca/Mg solution.  1 mL of the AOX cocktail was 
created prior to use, using the methods described in the preparation of AOX 
section.  Both plates were then taken to the irradiator and prior to radiation 
exposure AOX wells were aspirated of the PBS solution and treated with 100 µL 
of the AOX solution.  The plates were then exposed to 0 or 1 Gy of γ radiation.   
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During incubation with DCFH-DA, intracellular esterases will cleave acetate 
groups in the dye allowing it to “tag” oxygen species.  Further esterase cleavage 
of lipophilic blocking groups creates a charged form of the dye allowing the dye 
to be retained by the cell.  Upon oxidation of the cell through the generation of 
ROS, the dye becomes fluorescent (excitation: 492-495 nm; emission: 517-527).  
This fluorescence can then be measured and directly correlated to levels of ROS 
within the cells.  
 Immediately following radiation, the plates were then taken to a 
microplate reader and measured for fluorescent intensity using the conditions in 
TABLE 2. 
TABLE 2: Microplate Reader Settings 
 
As a positive control, freshly prepared 100 μM hydrogen peroxide (H2O2; 
Fisher Scientific) was added to all wells of the NR plate upon completion of its 
read as well as after the R plate’s reading.  The NR plate was replaced and read 
again with the addition of H2O2.  Similar methods applied to the R plate.  H2O2 is 
a form ROS and was used to validate the activity of the DCFH-DA.  Negative 
control conditions included samples with no cells with only DCFH-DA and cells 
SHAKING FLUORESCENCE INTENSITY 
Duration:  
30 sec. 
Excitation:           
485 ± 20 nm 
Lag Time:               
0 sec 
Settle Time:                          
0 sec.  
Amp. :         
3 mm. 
Emission:            






Mode: Top # of flashes: 25 




with no DCFH-DA to establish any auto-fluorescent levels.  Average fluorescent 
values in each well were reported from the plate reader and these values were 
then averaged in Microsoft Excel across all conditions (n=5) to find average 
DCFH-DA fluorescence per condition.  This level of DCFH-DA fluorescence 
directly relates to levels of active ROS present in HCFs.  The average 
fluorescence for each condition was then normalized to the NR no treatment 
condition.  The results were analyzed for equal standard deviations using 
statistical software (Minitab).  Significance is reported by using a one-way 
ANOVA coupled with a Tukey post-test (α=.05).  ANOVA residuals were 
examined to validate normal distribution. 
 
Determining ROS Damage to HCFs 
 An excessive production of γ-radiation induced ROS can lead to DNA 
damage. [56] Cells use the phosphorylated H2AX protein (γ-H2AX) as an indicator 
for DNA damage (double strand breaks).  Thus, this protein is used as a widely 
accepted immunofluorescent marker for DNA damage.  It was used here as a 
marker for any damage created by an excess in ROS production by ionizing 
radiation.  
Cells were seeded on fibronectin coated coverslips at 100% confluence.  
The discussed staining protocol was adapted from Wilson et. al [57].  After 
attachment the cells were treated with media containing 0.2% FBS for 2 days, 
halting proliferation of HCFs.  All samples were then subjected to either 0 or 1 Gy 
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of γ-radiation and treated with AOX appropriately.  Immediately following 
radiation, samples were fixed with a 4% formaldehyde (FA) solution (v/v) 
(Sigma) in DI H2O for 20 minutes.  Cells were then permeablized with a 0.1% 
triton solution (v/v) (Sigma) in 4% FA for 5 minutes.  This permeabilization step 
punctures micro-holes within the cellular and nuclear membranes in order for 
antibodies to enter the cell and to accurately find their targeted biomolecule.   All 
samples were then washed twice with 1X-PBS for 5 minutes each (this procedure 
here on out refers to “cells were washed”).  After permeabilization, the cells were 
then treated 30 minutes with an image ITFX signal enhancer (Thermo Fisher) 
which allows for the mitigation of any nonspecific binding.  Cells were then 
washed and treated with a 1:250 dilution of a primary antibody (anti-γ-H2AX; 
Millipore) for 1 hour at 37°C.  Once the cells were tagged with the primary 
antibody, samples were washed and treated with a 1:50 dilution of a secondary 
antibody (goat-anti mouse IgG CY3 conjugate; Millipore) for 1 hour at 37°C.  
Secondary antibodies are naturally fluorescent and are designed in order to tag 
the conjugated primary antibody, allowing for the target molecule, γ-H2AX in this 
case, to be visualized through fluorescent imaging.   
Post antibody treatments, cells were then washed and treated with a 4% 
FA solution for 20 minutes in order to crosslink the antibodies together to allow 
for optimal stability of the fluorescence in the secondary antibody.  Once the 
crosslinking step was completed, the cells were counterstained with a 1000 µM  
4', 6-diamidino-2-phenylindole-dihydrochloride (DAPI; Life Technologies) 
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solution for 5 minutes at room temperature (RT) in order to stain all nuclei.  Cells 
were then washed 3 times with 1X-PBS for 5 minutes each and then washed 
twice with DI H2O for 10 minutes each and then mounted on 3 inch microslides 
(VWR) with 15 µL of a fluorsave reagent (Millipore).  Slides were imaged using a 
Nikon Confocal microscope at 40X magnification.  Two images were taken for 
each coverslip.  Stains for γ-H2AX are concentrated foci within the nuclear 
regions of cells.  The numbers of foci per nuclei across all images was 
determined using Image J software and a Focinator macro created by NIH.  
Settings for this macro are listed in table 3.  Background and front channels were 
selected based on the arrangement of composite images within the software.  An 
automatic thresholding technique was used in order to mitigate subjective error.  
Through testing multiple thresholding processes, a Monuments design was 
decided upon due to its effectiveness in isolating the γ-H2AX foci.  In order to 
optimally select foci and to only have complete nuclei considered, the fill holes 
option was selected as well as all cells on the outer edges were discarded from 









Table 3: NIH Focinator Software Settings 
Focinator Settings 
Background Channel Blue 
Front Channel Red 
Manual Threshold No 
Mode of Threshold Monuments 
Fill Holes Yes 
Exclude Cells on Outer Edges Yes 
 
Nuclei were counted for each image and number of foci were counted 
using the find maxima setting within ImageJ.  Noise levels for foci counting were 
set based on NR conditions and preserved through all measurements.  Number 
of foci per nuclei were then calculated and averaged across coverslips and then 
averaged across all conditions (n=6, n=3 for NR-AOX) and normalized to the NR 
no treatment condition.  The n value of 3 for NR-AOX treatment was due to 
limited AOX resources and is preserved through all experiments for here on out.  
Results were analyzed for equal standard deviations by using software (Minitab).  
Significance was determined by completing a one-way ANOVA coupled with a 
Tukey post-test (α=.05).  ANOVA residuals were examined in order to verify 






Confirming TGF-β1 and SMAD 2/3 Activation in HCFs 
ROS is a known activator of TGF-β1 and the relative amount of it was 
verified by staining HCFs for TGF-β1.  Downstream signaling in response to TGF-
β1 binding to its cell receptor can lead to translocation of SMAD 2/3 to the 
nucleus.  SMAD 2/3 localization in the nucleus was also verified by staining HCFs 
for this protein in order to confirm activation of this pathway.  Cells were 
collected in a similar fashion as in the γ-H2AX protocol, minus the treatment with 
low serum media.  After 3 days of culture with media, all samples were taken to 
the irradiator and exposed to either 0 or 1 Gy of γ radiation and appropriate 
wells treated with AOX.  Cells to be analyzed for TGF-β1 were then fixed 
immediately [58], while SMAD 2/3 samples were fixed 6 hours post radiation. [59] A 
4% FA solution in 1X-PBS was given to the cells for 20 minutes for fixation.  Cells 
were then permeablized with a 0.1% triton solution in 4% FA for 5 minutes.  All 
sets of coverslips were then washed twice with 1X-PBS for 5 minutes for each 
wash.  This washing procedure will thus be referred to as “cells were washed.”   
After the initial washings, the cells were then treated with a 1:50 dilution (anti-
TGF-β1; Santa Cruz) or a 1:30 dilution (anti-SMAD 2/3; Santa Cruz) of a primary 
antibody and incubated for 1 hour at 37°C.  Once the cells were tagged with the 
primary antibody, they were then washed and treated with a 1:30 dilution of a 
secondary antibody (goat anti-rabbit IgG Alexa Flour 555 conjugate (AF 555); 
Life Technologies) for 1 hour at 37°C.  Once the secondary antibody was applied, 
the cells were washed and counterstained with a 1000 µM DAPI solution for 5 
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minutes RT in order to stain all nuclei.  Cells were then washed 3 times with 1X-
PBS and then washed once with DI H2O.  All coverslips were then mounted 
similarly as in the determining ROS damage section.  
 Slides were imaged using a Nikon Confocal microscope at 40X 
magnification.  Two images for each coverslip was obtained.  TGF-β1 slides were 
analyzed using Nikon Elements Advanced Research Analysis software by 
calculating the sum fluorescence intensity in each image.  Nuclei were counted 
for each image and the sum intensity for each image was normalized to the 
number of nuclei within each image.  These values were then averaged across 
coverslips and then averaged across all conditions (n=6, n=3 for NR-AOX).  
Average intensity per nuclei for all conditions were normalized to the NR no 
treatment condition.  An f test was completed in Minitab in order to confim equal 
variances.  If failed, a Games-Howell post-test was used.  Significance was 
determined by completing a one-way ANOVA coupled with a Games-Howell post-
test (α=.05).  ANOVA residuals were examined in order to verify normal 
distribution.   
Analysis of SMAD 2/3 was conducted in a similar fashion with the sum 
intensity only calculated within the nuclear regions of the images.  Nuclei were 
selected using the region of interest auto detect function within the software.  
Nuclear regions were only considered to be positive staining due to the 
localization of SMAD 2/3 within nuclei during times of its activation.  Sum 
intensity per nuclei of each coverslip was then averaged across all coverslips and 
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then averaged across all conditions (n=6, n=3 for NR-AOX). Results were 
analyzed for equal standard deviations by using software (Minitab).  Significance 
was determined by completing a one-way ANOVA coupled with a Tukey post-test 
(α=.05).  ANOVA residuals examined confirmed normal distribution.   
 
Determining Induction to Myofibroblasts 
The induction of HCFs to myofibroblasts was determined by staining HCFs 
for the myofibroblast indicator α-SMA.  Cells were prepared in a similar fashion 
as the γ-H2AX protocol, minus the treatment with low serum media.  Appropriate 
samples were treated with AOX and  irradiated on day 3 of culture and all sets 
were then fixed 24-36 hours post radiation.[60]  All fixation and staining 
procedures were the same as in the TGF-β1 and SMAD 2/3 section.  Cells were 
stained with a 1:100 dilution of a primary antibody (anti-α-SMA; Santa Cruz) and 
a 1:30 dilution of AF-555.  Coverslips were mounted using the same procedure in 
the determining ROS damage section.  Slides were imaged using the same 
procedure as in the TGFβ1 and SMAD 2/3 section.  Samples were analyzed 
similarly to TGF-β1 conditions with fluorescent intensity representing positive α-
SMA staining (n=6, n=3 for NR-AOX). Results were analyzed for equal standard 
deviations by using software (Minitab).  An f-test was completed in Minitab in 
order to test for equal variances.  If this test failed, a Games-Howell post used 
was used.  Significance was determined by completing a one-way ANOVA 
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coupled with a Games-Howell post-test (α=.05).  ANOVA residuals examined 
confirmed normal distribution. 
Visualizing the HCF Microenvironment and Isolation of dECM 
The total composition and structure of the cell-ECM environment was 
visualized by staining HCFs with a 1:100 dilution of an AF 488 carboxylic acid, 
succinimidyl ester amino probe (Life Technologies) in order to fluorescently tag 
all proteins.  Cells required for this experiment were acquired on fibronectin 
coated coverslips after 14 days of culture with radiation on day 7.  All fixation, 
staining, and mounting procedures are similar to the confirming TGF-β1 and 
SMAD 2/3 activation in HCFs.  Images taken were used as a qualitative analysis 
for comparing protein structure and amount for each condition.   
To examine the effects of radiation on ECM remodeling, the HCFs were 
extracted leaving an intact ECM to examine.  Appropriate cells were treated with 
AOX and irradiated on day 7 of culture.  On day 14 of cell culture, fibronectin 
coated coverslips or cell culture plates for all conditions were removed of cell 
culture media and rinsed with 1X-PBS.  A 0.1% triton X-100 solution (v/v) was 
then added to each well containing coated coverslips or wells.  Plates were 
placed onto a rocking plate and left at RT for 5-7 minutes to allow dissolution of 
cellular membranes.  Once membranes were removed, 100 µL of a 0.1% solution 
of DNAse I solution (Roche) was placed into the same wells and allowed to 
incubate for 1 hour at 37°C, or until all nuclei were no longer present.  
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Decellularized ECM (dECM) samples were then rinsed twice with 1X-PBS and 
then used for the appropriate experiments described in upcoming sections.   
 
Examining Composition Changes in dECM 
The composition of dECM (FN, Col III and I, and elastin) was determined 
by staining dECMs for the all of the antibodies specific for these proteins.  All 
fixation and staining procedures are described in all previous antibody staining 
sections.  FN, Col III and elastin were stained on the same coverslips with 1:200, 
1:10, 1:100 (respectively) dilutions of their primary antibody (anti-FN; abCAM) 
(anti-col III; SouthernBiotech) (anti-elastin; Santa Cruz).  Samples were then 
treated with 1:30, 1:50, and 1:100 dilutions of AF 555, AF 488, and AF 350, 
respectively.  (Life Technologies)   Col. I was stained solely using a 1:200 dilution 
of its primary antibody (ant-col I; abCAM) and a 1:50 dilution of AF 488.            
1 z-stack was taken for each coverslip on a Nikon confocal microscope at 40X 
magnification.  Z-stacks allow for a 3D view of the dECM environment.  These 
stacks were then analyzed using the Nikon analysis software in order to 
determine the volume of each protein present and the dECM’s anisotropy. 
Volume is determined by thresholding each image within the z-stack and 
applying this threshold to all images within the stack.  This threshold selects all 
positive stainings of the individual proteins.  Thresholds were determined by 
selecting the values between 0 and 4095 (representing a 12 bit color image) that 
maximized protein selection while minimizing noise selection.  Threshold values 
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were preserved across all conditions.  Once thresholds were applied, the volume 
measurement tool in the software calculates a volume of protein selected based 
on the threshold.  A percent protein can be determined by computing the ratio of 
volume of the thresholded protein to that of the total volume of the stack.  
These values were then averaged across all coverslips and all conditions (n=6 for 
NR and R conditions, n =3 for NR-AOX and R-AOX conditions).  Volume results 
were analyzed for equal standard deviations by using software (Minitab).  
Significance was determined for volumes by completing a one-way ANOVA 
coupled with a Tukey post-test. (α=.05) Residuals were analyzed in order to 
confirm normal distribution.    
 
Examining Structural Changes in dECM 
Thickness and anisotropy measurements were taken in order to 
investigate any structural changes in dECM post γ-radiation exposure.  Thickness 
measurements were reported from the collection of z stack measurements and 
then averaged across all coverslips measured (n = 9 for NR and R conditions, n 
=3 for NR-AOX and R-AOX conditions). Lower n values were again due to limited 
AOX resources.  Average thickness for all z-stacks were then normalized to the 
NR no treatment condition.  Thickness measurements were analyzed for equal 
standard deviations by using software (Minitab).  Significance for thickness 
measurements was determined by completing a one-way ANOVA coupled with a 
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Games-Howell post-test (α=.05).  ANOVA residuals were examined in order to 
verify normal distribution. 
Structural organization of the dECM produced was analyzed by examining 
the anisotropy, or preferred direction, of the dECM fibers.  Maximum intensity 
projections (MIPs) were taken from each z-stack which allow to view the highest 
level of fluorescence within all z-stack images in one composite image.  Each MIP 
was analyzed for anisotropy using the FibrilTool macro in ImageJ. [61] This macro 
measures the fractional anisotropy ratio of fibers within any microscopy image 
based on the concept of a second order nematic tensor [62].  An area drawn 
around the entire image was measured for its respected anisotropic value 
ranging between 0 (less ordered; less restriction) and 1 (more order; more 
restriction).  Anisotropy fractions were averaged across all conditions (n=6 for 
NR and R, n = 3 for NR-AOX and R-AOX) in Microsoft Excel and normalized to 
the NR no treatment condition.  Minitab was used in order to test for equal 
variances.  Significance is determined by using a one-way ANOVA along with a 
Tukey post-test (α=.05).  ANOVA residuals were examined in order to verify 
normal distribution. 
 
Quantification of Proteins Produced in dECM 
The relative amount of proteins produced in ECM was determined by 
using a bicinchoninic acid (BCA) assay adapted from Sigma Aldrich.  ECM 
required for this experiment for two (NR and R) conditions (5 per condition) was 
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obtained in 6 well plates using methods described in the production of ECM and 
isolation of ECM sections.  Once decellularized, all ECM samples were placed on 
ice and solubilized in 125 μL of a radioimmunoprecipitation (RIPA) buffer 
(constituents listed in table 4).  Samples were rotated for 3 minutes to allow for 
proper distribution of RIPA buffer and then each well was scraped with a sterile 
cell scraper (Falcon).  Samples were then allowed to sit on ice for 3 additional 
minutes to allow for optimal solubilization of ECM proteins.  This protein-RIPA 
solution was collected and used in the BCA assay.   
 
TABLE 4: RIPA Buffer Components 
SOLUTION VOLUME COMPANY 
50 mM Tris Base + 
150 mM NaCl 
9.5 mL Sigma 
100 mM Sodium 
Orthovanadate 
200 µL Sigma 
200 mM EDTA 100 µL Amresco 
10% (w/v) Sodium 
Deoxycholate 
100 µL Sigma 
10% (v/v) Triton X-
100 
100 µL Sigma 
10 mM Leupeptin 42 µL Sigma 
20 mg/mL Aprotonin 10 µL Sigma  
 
Once the ECM was solubilized and collected, 10 μL of samples from each 
condition was pipetted into a 96 well plate.  5 replicates of each sample were 
used.  Additionally, 10 μL of standards ranging from 0 to 10 μg of protein were 
pipetted into the plate in 5 replicates.  Standards were created by serial dilutions 
of a 1 mg/mL bovine serum albumin solution in RIPA buffer.  Once all samples 
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were prepared in the plate a working reagent (WR) was created by mixing two 
separate reagents (A and B; Thermo Scientific) in the ratio of 50:1 based on the 
necessary amount needed for each plate.  Samples and standards were mixed in 
the plate with a 1:8 ratio of the WR.  Once mixed, the plate was incubated for 30 
minutes at 37°C to allow for the WR to react with any present proteins.  All 
plates were read for absorbance at 562 nm using a BioTek microplate reader 
with the conditions in table 5.  
TABLE 5: Microplate Reader Settings 
PARAMETER SETTING 
Assay Quick Read 
Wavelength Single  
Measure 562 nm 
Plate Type 96 well 
 
This biochemical assay measures protein concentrations within a solution.  
This is accomplished by using a known two-step reduction of Cu+2 to Cu+1 by 
proteins in alkaline mediums (the WR) using highly sensitive colorimetric 
detection of the Cu+1 cation by BCA.  
Within the first step of the reaction, samples are introduced into an 
alkaline environment to form light blue complexes.  These complexes then react 
with BCA to produce an intense purple-colored reaction, strongly influenced by 
amino acid residues, that results from the chelation of two molecules of BCA with 
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one Cu+1 ion.  This purple complex is water-soluble and exhibits a strong linear 
absorbance at 562 nm.  
Absorbance measurements obtained from the microplate reader were then 
averaged across each sample using Microsoft Excel.  Using the standards, 
average absorbance was then translated into average protein amounts.  Only 
assays resulting in less than 10% standard deviation among the standards were 
considered.  These were then averaged across all conditions (n=5) and then 
normalized to the NR no treatment condition.  Data obtained was then tested in 
Minitab for normal distribution and equal variances.  Statistical significance was 
determined by using a t-test (α=.05).  Normal distribution was verified by 
examining probability plots of the data collected.   
 
Confirming Functional Endothelial Cell Changes on dECM  
 To determine if the changes in dECM alter endothelial cell (EC) function, 
an aorta outgrowth assay was adapted from K Soucy et. al.[63]  C7BL6 control 
mice from another study were injected with a 0.9% physiological saline buffer 
and were sacrificed 10 days post injection.  Aortas were surgically isolated and 
cut into 1-2 mm sections.  A section of each aorta was placed onto NR and R 
dECM prepared in a 6 well plate using methods described in the isolation of 
dECM section.  Aortas were allowed to attach to the dECM for 1 hour at 37ºC.  
Post incubation, 3 mL of media supplemented with 0.0% FBS + 1.0% 
PS/Glutamine (Gibco Medium 200; Life Technologies) was added slowly to each 
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well, allowing the media to cover the aorta.  Aortas were allowed to culture in 
this media for 5 days with no media change.  On the fifth day, aortas were fixed 
using a 4% FA solution for 1 hour at RT and then imaged.   
Phase contrast images were taken using a Nikon epifluorescent 
microscope at 10x magnification.  Two images per aorta were taken (3 NR dECM, 
2 R dECM).  Images were thresholded using software (Nikon Elements) in order 
to isolate the growth area within each image by setting a threshold on the image 
limiting brightness (0 to 4095) and size (0 to 5 µm).  A polygon representing the 
growth area was drawn using the polygon feature in the software.  Area of the 
polygon and area of thresholded areas within the polygon were then measured 
using the measure function in the software.  A percentage of area covered by 
ECs within the growth area was then calculated using Microsoft excel.  Threshold 
values were preserved across both conditions.  An average EC outgrowth area 
percentage was calculated using Microsoft Excel and normalized to the NR no 
treatment condition.  Results were tested for equal variances and normal 
distribution using Minitab.  Significance was determined by using a paired t-test 
(α=0.5).  
 
III. RESULTS AND DISCUSSION 
Detection of ROS in HCFs 
 ROS levels were measured by analyzing average fluorescence of DCFH-DA 
in cells for all conditions.  Results shown in figure 1 show a significant increase in 
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ROS levels by approximately 20% (p*=.020) between NR and R conditions as 
well as a significant decrease in ROS in both conditions treated with AOX when 
compared to their no treatment conditions (p** and p*** < 0.0001). In addition, 
we observe an increase in ROS for NR-AOX and R-AOX conditions, suggesting 
slightly more ROS produced in R-AOX conditions.  This verifies that exposure to 
γ-irradiation increases the levels of ROS within the fibroblastic model. 
 
 
Fig. 1: Relative fluorescent units in HCFs subjected to 0 and 1 Gy of γ radiation with and 
without AOX treatment.   
 
 
Determining ROS Damage to HCFs  
ROS induced DNA damage to HCFs was examined by staining cells for a 
marker of DNA damage, γ-H2AX, and analyzed using computer software (Image 
J; Focinator).  Representative images of γ-H2AX staining for each condition are 
shown in figure 2.  The same images are shown in figure 3 after being ran 




































increase in γ-H2AX foci in radiated HCFs (p* = .0004).    Moreover, not radiated 
samples treated with AOX expressed significantly decreased numbers of foci (p** 
< .0001) when compared to NR samples.  Additionally, radiated samples treated 
with AOX had significantly less foci per nuclei when compared to the R condition 
(p*** < .0001) indicating that γ-H2AX foci present are dependent on AOX 
treatment in both NR and R conditions.  Moreover, we observed a nearly 2 fold 
increase of foci present in R-AOX conditions when compared to NR-AOX 
conditions, indicating further ROS dependent expression of γ-H2AX.               
The increase of ROS in radiated HCFs and the presence of γ-H2AX foci in HCFs 
following γ-radiation exposure indicates that HCF are radiosensitive and that both 











Fig. 2: Immunofluorescent images of γ-H2AX foci within HCFs for all conditions: (A) No 
Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with AOX.  Scale bar 





























Fig. 3: Threshold results of running γ-H2AX images through the focinator software.  (A) No 










































































Confirming TGFB and SMAD 2/3 Activation in HCFs 
 
Relative levels of activation of TGF-β1, a known pro-fibrotic growth factor, 
was analyzed by staining for any TGF-β1 present in HCFs for all conditions.   
Representative images of TGF-β1 staining for each condition are shown in figure 
5. Sum intensity per nuclei was measured (figure 6) and shows a significant 10-
fold increase in TGF-β1 staining expression in radiated HCFs (p* < .0001).  This 
increase is significantly attenuated in radiated samples treated with AOX       
(p** < .0001) while the no radiation samples treated with AOX are statistically 
similar to the NR no treatment condition.  This trend of TGF-β1 production 
suggests that this pro-fibrotic growth factor is also a consequence of γ-radiation 












Fig. 5: Immunofluorescent images of TGF-β1 activation within HCFs for all conditions: (A) No 
Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with AOX.  Scale bar 





















SMAD 2/3 is activated in the presence of TGF-β1 and is a key contributor 
in the regulation of many pro-fibrotic proteins.  Thus, SMAD 2/3 was stained for 
in HCFs for all conditions with representative images of SMAD 2/3 staining for 
each condition shown in figure 7.  Images showing the regions of interest 
analyzed are shown in figure 8.  Sum intensity of SMAD 2/3 staining in the 
nuclear regions was measured (figure 9) and shows a reluctant increase in SMAD 
2/3 staining expression in radiated HCFs by 30% (p = .110).  This increase is 
significantly mitigated in radiated samples treated with AOX (p* = .003) while 
the NR samples treated with AOX are similar to the NR no treatment condition.  
Moreover, we observed a 30.8% increase of SMAD 2/3 present in R-AOX 
conditions when compared to NR-AOX conditions, indicating further ROS 























































suggests that the SMAD 2/3 pro-fibrotic pathway is additionally triggered by γ-
radiation exposure and is also ROS sensitive (most likely as a result of the 

















Fig. 7: Immunofluorescent images of SMAD 2/3 activation within HCFs for all conditions: (A) 
No Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with AOX.  Scale bar 








































Fig. 8: Images with nuclear regions of interest selected for SMAD 2/3 images for all conditions: 















































































Determining Induction to Myofibroblasts 
 Myofibroblasts are widely associated with their involvement in the excess 
production of proteins.  α-SMA is a widely accepted marker for their expression 
and was stained for in order to validate the presence of myofibroblasts.  
Representative images of α-SMA staining for each condition are shown in figure 
10. Sum intensity per nuclei of each image was measured and data shown in 
figure 11 suggests a significant 2.5 fold increase in α-SMA staining expression in 
radiated HCFs (p* = .0008).  Moreover, this increase is significantly decreased in 
radiated conditions treated with AOX (p** < .0001).  This activity indicates a γ-
radiation and ROS dependent expression of α-SMA thus further suggesting that 
downstream effects γ-radiation exposure can include a fibroblasts induction to 






















Fig. 10: Immunofluorescent images of α-SMA expression within HCFs for all conditions: (A) No 
Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with AOX.  Scale bar 












































































Visualizing the HCF Microenvironment and Isolation of dECM 
 
 The HCF microenvironment is a multi-faceted combination of cells and 
ECM.  This environment is visualized in figure 12 with MIP images for each 
condition.  These images show a distinct structural difference in radiated samples 
as well as a brighter staining in radiated samples which could indicate an 
increased presence of protein.  The ECM was decellularized (figure 13) in order 
to further investigate composition and structural changes to the ECM post γ-
radiation exposure.  The lack of cells in 13B indicates that the detergent based 
decellularizatoin protocol is an effective tool for isolating the ECM produced by 
HCFs.   
 











Fig. 12: Representative images of the amino probe all protein stain within ECM for all 
conditions: (A) No Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with 



























Fig. 13: Phase contrast images of (A) cellularized extracellular matrix (ECM) and decellularized 
ECM (B).  Scale bars indicate 100 µM.   
 
Examining Composition Changes in dECM 
Representative composite maximum intensity projection (MIP) images for 
the 3 channel ECM stained coverslips are shown in figure 14 for each condition.  
Individual MIP images for FN and Col III channels are shown in figures 15 and 
17, respectively. MIP images for the 1 channel ECM stained coverslips are shown 
in fig 19 for the NR and R conditions. Thresholded images of FN, Col III, and Col. 
I are shown in figures 16, 18, and 20 respectively.  Elastin stains and volumes 
are not reported due to no positive staining being observed.  AOX treated 
collagen I conditions are not shown due to no observable difference in NR and R 
no treatment conditions.  Relative fold increases of FN, Col III, and Col I volumes 
are shown in figure 21.  Volume measurements show a significant 2 fold increase 
in FN volume in radiated HCFs (p* = .0105).  Additionally, the same trend is 
observed with a 50.7% increase in FN production in R-AOX conditions when 
compared to NR-AOX.    Furthermore, radiative groups treated with AOX show a 















































(p*** = .0075).  Fibronectin is a main ECM protein and when produced in 
excess, as seen in radiative environments, is indicative of fibrosis environments. 
Production of collagen I is decreased significantly by almost 80% between NR 
and R conditions (p**=.036).  All other conditions for collagen I production were 
statistically similar. This contradictory result shown here to decrease in dECM by 
75% is most likely indicating that collagen production is mandated by cells other 
than HCFs, most likely smooth muscle cells, and/or is modified by ECM 
remodeling proteins (cathepsins) post radiation exposure. No statistical 
difference was observed in collagen III production, although there was an 











Fig. 14: Composite maximum intensity projection images of fibronectin, collagen III, and 
elastin expression within dECM for all conditions: (A) No Radiation, (B) Radiation, (C) No 






















































Fig. 15: MIPs of fibronectin expression within dECM for all conditions: (A) No Radiation, (B) 
Radiation, (C) No Radiation with AOX and (D) Radiation with AOX.  Scale bar indicates 50 





















Fig. 16: Representative thresholded images of fibronectin expression within dECM for all 
conditions: (A) No Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with  


























































Fig. 17: MIPs of collagen III expression within dECM for all conditions: (A) No Radiation, (B) 
Radiation, (C) No Radiation with AOX and (D) Radiation with AOX. Scale bar indicates 50 




























Fig. 18: Representative thresholded images of collagen III expression within dECM for all 
conditions: (A) No Radiation, (B) Radiation, (C) No Radiation with AOX and (D) Radiation with 











































Fig. 19: Representative images for collagen I production in NR (A) and R (B) conditions within 
















Fig. 20: Thresholded images for collagen I production in NR (A) and R (B) conditions within 





Fig. 21: Relative amounts of fibronectin (black), collagen III (gray), and collagen I (orange) 



























Fibronectin and Collagen I and III 
Production in dECM 
































Examining Structural Changes in dECM 
Structural changes to the dECM measured post γ-radiation exposure 
included the thickness and anisotropy of the dECM.  Thickness measurements 
are presented in figure 22 and show a significant 60% increase in ECM thickness 
between NR and R conditions (p*=.0005).  In addition, this increased ECM 
thickness is significantly decreased in R and RAOX conditions (p**=.0059).  
Collectively, this relationship implies protein production, and thus the thickness 
of ECM, is increased in response to γ-radiation and is dependent on the presence 
of ROS.  Isotropic measurements are shown in figure 23 and report a significant 
decrease in anisotropy (1 versus .23) between NR and R conditions (p*=.0004) 
thus significantly altering the fibril structure and alignment of dECM.  Moreover, 
in AOX treated conditions, we observe a 23% decrease in anisotropy in R-AOX 
conditions when compared to NR-AOX conditions.  Interestingly enough though, 
not only is radiation a contributor to anisotropy, but data shows here that 
exogenous AOX treatment has a significant toll on dECM order.  NR and R 
conditions treated with AOX are statistically less anisotropic (.4 and .3, 
respectively) when compared to the NR no treatment condition (p**N-NA =.0122 
and P***N-RA=.0044, respectively).  This affect will have to be studied more in 
order to obtain a clearer understanding of the chemistry involved in the 
treatment of the AOX cocktail as well as the effect of AOX on the dECM.  
Nonetheless, the more significant alteration in structure observed in radiated 
dECM ultimately has the capacity to affect a slew of cellular and molecular 
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characteristics possibly leading to the phenotypical conditions observed in 
diseased cardiovascular states.   
 
 





Fig. 23: Relative anisotropic values for dECM treated with 0 or 1 Gy for all experimental 
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Quantification of Proteins Produced in dECM 
 Concentration of proteins produced in the dECM were quantified by using 
the BCA assay.  Data (figure 24) expresses a significant increase of protein 
concentration in R samples when compared to NR samples (p* = .0047).  This 
increase thus insinuates that radiation exposure contributes to an increased 
protein production, most likely through the action of the TGF-1 and SMAD 2/3 
pro-fibrotic pathways.  Moreover, this increased production of proteins is 
primarily done through the action of HCFs induced to myofibroblasts.   
 
 
Figure 24.  Protein Production in R and NR HCF derived dECM. 
 
Confirming Functional Endothelial Cell Changes on dECM  
Representative images for EC outgrowth are shown in figure 25.  These 
same images are shown thresholded in figure 26.  The analysis of EC outgrowth 






































dECM.  However, no significant changes (p =.499) are reported notably due to 






































































































IV. CONCLUSIONS AND FUTURE WORK 
 The first aim of this work was to develop a fibroblast cell culture model that 
allows for the production of a cardiovascular specific decellularized ECM.  Human 
cardiac fibroblasts were successfully cultured and used in order to produce a cell-
ECM microenvironment.  This cell-ECM scaffold was then used in order to 
elucidate the radiative effects on cell activity in an effort to connect radiation 
exposure to fibrotic consequences.  It was verified here that the ECM component 
can be decellularized successfully using detergent based methods.  This HCF 
derived dECM was then used in order to additionally study effects of exposure to 
γ-radiation.  Future studies on HCF derived dECM can supplement information 
regarding its composition, microstructure, biochemical properties, and bioactivity 



























  Second, it was an aim of this work to study the radiosensitivities of the 
fibroblastic model exposed to γ-radiation.  We verified that exposure to γ-
radiation increases the levels of ROS within the fibroblastic environment.  ROS 
are known activators of pro-fibrotic signaling cascades and have already been 
linked to the activation and/or expression of pro-fibrotic growth factors and 
proteins.  γ-H2AX foci studies completed support the idea that HCFs are 
radiosensitive to increased ROS levels.   
  ROS has been shown to efficiently activate the TGF-β signaling pathway 
which is a known player in the upregulation of fibrotic genes.  It achieves its goal 
through the activation of the SMAD 2/3 nuclear pathway which upon activation 
upregulates fibrotic gene transcription.  Through examining both of these 
proteins, this work verified that both proteins are sensitive in response to ROS 
production thus suggesting that γ radiation exposure is also an activator of the 
TGF-β1 and SMAD 2/3 pathway.  Increased production of fibrotic proteins, as a 
result of an activated SMAD 2/3 pathway, are normally characterized by the 
presence of myofibroblasts.  We additionally verified that upon γ-radiation 
exposure there is a significant increase in α-SMA expression, which is also ROS 
sensitive.  Collectively, this HCF activity suggests that downstream effects of γ-
radiation exposure can include pro-fibrotic events in HCFs.  We thus continued 
our investigation into ECM level changes in response to γ-radiation exposure.      
  The ECM is the supportive framework for fibroblasts that mandate most 
aspects of a cells life in-vivo and in-vitro.  We utilized an HCF derived ECM in 
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order to study the changes to the ECM function, including its composition, 
structure, and effects on cellular activities post γ-radiation exposure.  Fibronectin 
is a key fibrotic protein that is known to be heavily influenced by the activity of 
TGF-β1.  We observed an inherent increase in fibronectin production, along with 
increased TGF- β1, and additionally report that FN production is ROS sensitive, a 
result strongly correlated with effects of pro-fibrotic cell signaling cascades 
studied here.  Surprisingly, it was observed that both collagens decreased in 
response to radiation exposure.  This contradiction suggests collagen production 
is mandated by more than just fibroblasts or moreover, modified post-radiation 
by ECM remodeling proteins, such as cathepsins, and will be investigated further 
in future studies.  However, analysis of all proteins produced suggests a trend 
globally supporting an increased protein production in response to γ-radiation 
exposure.  Future work will include investigating the AOX treated conditions 
when studying all proteins produced.   
  Structural studies examined the thickness and anisotropy of the ECM 
produced post radiation exposure. Thickness of radiated dECM was increased 
implying the presence of more proteins produced in radiative conditions.  
Additionally, in the presence of AOX the thickness of dECMs were comparable to 
NR groups.  Collectively, this relationship also implies protein production is 
altered in response to γ-radiation and is dependent on the presence of ROS. 
Moreover, the structural dispersion of ECM fibrils was studied by examining 
anisotropy of the dECM produced.  Under radiative conditions, the ECM is less 
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ordered, or less anisotropic thus altering the fundamental structure of ECM.  
Interestingly enough, not only is radiation a contributor to anisotropy, it was 
shown here that exogenous AOX treatment has a significant toll on dECM 
organization.  This affect will have to be studied more in order to obtain a clearer 
understanding of the chemistry involved in the treatment of the AOX cocktail and 
its interactions with ECM molecules. Nonetheless, the alteration noted in radiated 
samples (samples with the least anisotropy) in structure observed is known to 
affect ECM characteristics possibly leading to the phenotypical conditions 
observed in diseased cardiovascular states. 
  Lastly, endothelial cell outgrowth onto ECM was examined in response to 
γ-radiation exposure in order to see if radiated ECM can alter a cells function.  
Although not significant, a clear result of this study was that cell migration onto 
ECM was hindered on radiated ECM.  This is key in suggesting that the ECM 
plays a critical role in determining the fate of cells in its environment, both under 
not radiated and radiated conditions  Altered cell functions and activity are 
certainly known to contribute to the conditions observed in diseased 
cardiovascular states.    
We hypothesized that an HCF in vitro model can be designed in order to 
show that γ-radiation exposure increases ROS which contribute to the increased 
production of ECM proteins thus, altering their structure and function.  We 
investigated this task by completing radiosensitivity studies on HCFs and their 
ECM, seeing a general trend supporting the idea the γ-radiation increases protein 
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production and changes the molecular make up of cells and ECM.  Moreover, it is 
shown here that γ-radiation exposure appears to be strongly associated with pro-
fibrotic events characterized with many cardiovascular disease pathologies.  This 
is deducted by observing increased expression or activation of γ-H2AX, TGF-β1, 
SMAD 2/3, α-SMA, increased FN and overall protein production, and an increase 
in thickness and decrease in anisotropy. Clearly, this fibroblastic model has 
proven itself to be able to provide a novel platform to study radiation-induced 
changes to HCFs and ECM. 
Future work will focus on improvements leading towards the progression 
to study in-vivo changes such as: (1) utilize additional quantification techniques 
to explore activation and production of proteins in both HCFs and dECM (2) 
include nuclear level investigations of pro-fibrotic gene changes in similar 
conditions and (3) expand the outgrowth assay to include an increased n-value 
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